{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE300nnn/GSE300353/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by array"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300353"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Transcriptomic analysis of CAFs with silencing of TERRA lnRNA","description":"The tumor microenvironment is essential for cancer progression, yet the nuclear mechanisms that reprogram stromal fibroblasts into cancer-associated fibroblasts (CAFs) remain to be defined. Here, we identify a telomere-derived RNA–protein signaling axis that links genome integrity and fibroblast plasticity. We show that the long non-coding RNA TERRA, transcribed from telomeres, is upregulated in CAFs across multiple human skin cancers following loss of androgen receptor (AR) expression. Elevated TERRA enhances telomeric DNA damage and activates a CAF-specific transcriptional program. Through proteomic profiling, we identify the RNA-binding protein NONO as a critical TERRA effector. TERRA and NONO form nuclear complexes selectively in CAFs, while in normal fibroblasts NONO associates with AR. Disruption of the TERRA-NONO complex, either by genetic silencing or a small-molecule inhibitor of NONO, reverses CAF activation and suppresses tumor-stroma cells expansion in vitro and in vivo. These findings uncover a telomere-encoded mechanism of stromal reprogramming and identify the TERRA–NONO complex as a targetable point of vulnerability in the tumor microenvironment.","dates":{"publication":"2026/08/10"},"accession":"GSE300353","cross_references":{"GSM":["GSM9058976","GSM9058978","GSM9058977","GSM9058979","GSM9058981","GSM9058980"],"GPL":["23126"],"GSE":["300353"],"taxon":["Homo sapiens"]}}